Company / Assets per Share
SELLAS Life Sciences Group, Inc. Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.32
FY2024
5-year range
$0.30 / $9.06
FY2020-FY2024
Trend
+7.2%
vs FY2023
Sector context
#208 of 210
Health Care
What the data says
Among 210 Health Care companies, SELLAS Life Sciences Group, Inc. is in the bottom 1% for assets per share. Assets per Share returned to growth in FY2024 after 3 years of decline, reaching $0.32.
Based on SEC 10-K filings.
0.32 in FY2024 with a 5-year CAGR of -45.3%.
Declined from $1.32 to $0.32 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -44.4%
- 5-Year CAGR
- -45.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 210This company $0.32 Sector average $353.15
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2024, assets per share increased 7.2% year-over-year.
- Ranks #208 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2018.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.32 | +7.2% |
| FY2023 | $0.30 | -77.5% |
| FY2022 | $1.32 | -28.5% |
| FY2021 | $1.84 | -79.7% |
| FY2020 | $9.06 | +39.6% |
| FY2019 | $6.49 | -90.0% |
| FY2018 | $64.67 | +351.5% |
| FY2017 | $14.33 | +1706.3% |
| FY2016 | $0.79 | +5.6% |
| FY2015 | $0.75 | +2.1% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026